Guidance Document: Data Protection under C.08.004.1 of the Food and Drug Regulations

Canada’s obligations under the North American Free Trade Agreement and the Agreement on Trade-Related Aspects of Intellectual Property Rights require the granting of protection for undisclosed test or other data necessary to determine the safety and effectiveness of a pharmaceutical product which utilizes a new chemical entity, the origination of which involved considerable effort.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-07-05

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data